My Companies
Notification
Account
USFDA issued 18 Nov 2026 warning letter for Amaliya, Daman facility after 20 Apr-1 May 2026 inspection earlier classified OAI. Company to respond; says approved-product US supply continues with no material impact.
Alkem Laboratories Appoints Dr Amrut Naik As Chief Executive Officer
Alkem Laboratories Announces CFO Nitin Agrawal Resignation Effective September 30
Alkem Laboratories Receives US FDA OAI Classification For Daman Facility